Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989;36(3):291-7.
doi: 10.1007/BF00558162.

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure

Affiliations
Comparative Study

Paracetamol disposition and metabolite kinetics in patients with chronic renal failure

L F Prescott et al. Eur J Clin Pharmacol. 1989.

Abstract

The disposition of paracetamol following an oral dose of 1.0 g was compared in 10 healthy volunteers, 7 patients with moderate chronic renal failure and 6 patients with end stage renal failure on maintenance haemodialysis. Paracetamol absorption was normal in the patients with renal failure. The mean plasma half-life of paracetamol from 2 to 8 h was similar in the 3 groups (2.1 to 2.3 h) but from 8 to 24 h it disappeared much more slowly in the renal failure patients (half-life 11.7 compared with 4.9 h in the healthy volunteers). Plasma concentrations of paracetamol glucuronide and sulphate conjugates were greatly increased in the patients with moderate renal failure and the mean plasma half-lives were 30.5 and 21.8 h respectively compared with about 3 h in the healthy volunteers. Plasma concentrations of these metabolites were even higher in the dialysis patients and there was no significant fall over 24 h. The cysteine and mercapturic acid conjugates of paracetamol could only be measured in plasma in the patients with renal failure and concentrations were very low. The fractional urinary recovery of paracetamol and its glucuronide, sulphate, cysteine and mercapturic acid conjugates was similar in healthy volunteers and patients with moderate renal failure.(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharm Pharmacol. 1976 Sep;28(9):707-9 - PubMed
    1. Br J Clin Pharmacol. 1982 Feb;13(2):145-53 - PubMed
    1. Br J Clin Pharmacol. 1986 Sep;22(3):363-6 - PubMed
    1. Clin Pharmacol Ther. 1980 Oct;28(4):449-55 - PubMed
    1. Clin Pharmacokinet. 1981 Sep-Oct;6(5):329-45 - PubMed

Publication types

LinkOut - more resources